US-based Bio-Techne & Thermo Fisher Scientific Forge Distribution Partnership

From May 1, 2024, Thermo Fisher's European arm, the Fisher Scientific Channel, will distribute Bio-Techne's products across European research institutions and labs.

US-based Bio-Techne Corporation, a prominent player in the life sciences industry, has teamed up with Thermo Fisher Scientific, a leader in laboratory products and services, to democratize access to advanced healthcare solutions. 

Effective May 1, 2024, this partnership will see Thermo Fisher's European arm, the Fisher Scientific Channel, distribute Bio-Techne's extensive range of products, including antibodies, proteins, immunoassay kits, reagents, and enzymes, to research institutions and laboratories across Europe.

Commenting on the partnership, Kim Kelderman, president and CEO of Bio-Techne, said, "Partnering with Thermo Fisher marks a significant step in our mission to empower researchers and accelerate scientific discoveries.” 

Kelderman added that by leveraging Thermo Fisher's expansive distribution network and industry expertise, they aim to facilitate breakthroughs in healthcare.

Strengthening Industry Position

Echoing similar sentiments, Claire Wallace, president of research and safety market, Europe at Thermo Fisher, said, "We are committed to providing scientists and researchers with access to the latest technologies and expertise. By integrating Bio-Techne's high-quality products into our portfolio, we aim to drive advancements in healthcare."

The distribution agreement underscores both companies' dedication to fostering innovation and collaboration within the scientific community. 

By joining forces, Bio-Techne and Thermo Fisher aim to strengthen their position as trusted partners for researchers and laboratories across Europe, ultimately advancing scientific knowledge and improving healthcare outcomes.

Incorporated in 1976, Bio-Techne Corporation is a global life sciences company committed to providing innovative tools and bioactive reagents for research and clinical diagnostics. Its products support scientific investigations into biological processes and disease progression.

Thermo Fisher’s Recent Healthcare Developments

Recently, the Atal Incubation Centre – Centre for Cellular and Molecular Biology (AIC-CCMB) in Hyderabad has allied with Thermo Fisher Scientific to equip AIC-CCMB’s cutting-edge facility, the Centre for Innovation, with state-of-the-art technology to support the growth and development of startups in the field.

Per the agreement, Thermo Fisher Scientific will provide advanced technological infrastructure to empower scientists and entrepreneurs associated with AIC-CCMB’s Centre for Innovation. 

In January, Thermo Fisher Scientific appointed Srinath Venkatesh as MD of India and South Asia. Talking about his vision, Venkatesh highlighted his goal of advancing the company's growth and operations in India while enhancing customer value creation. 

Since 1996, when Thermo Fisher established its operations in India, the company has strengthened its presence with eight manufacturing facilities, five application labs, two R&D centers, and eight distribution centers.

This was supported by an extensive network of 400-plus channel partners and approximately 4,700 employees (including PPD) strategically located in 42 cities and offices across 17 locations.

Going forward, Thermo Fisher Scientific plans to launch ‘Lab of the Future’. This involves building an integrated ecosystem between analytical instruments, software, and data. 

Further, the company aims to automate and connect instruments, overcome people, process, and technology hurdles, and enable businesses to innovate continuously.

Last year, Thermo Fisher Scientific and Pfizer entered into a collaboration agreement to help increase local access to next-generation sequencing (NGS)-based testing for lung and breast cancer patients in more than 30 countries across Latin America, Africa, the Middle East, and Asia.

With an annual revenue of more than $40 billion, Thermo Fisher Scientific is an American supplier of analytical instruments, life sciences solutions, specialty diagnostics, laboratory, pharmaceutical, and biotechnology services. The company aims to enable its customers to make the world healthier, cleaner, and safer.